Datavant is dedicated to accelerating the discovery, development, and commercialization of new medicines through machine learning. It aims to partner with biomedical research institutions to eliminate silos of information and unlock insights from healthcare data. The firm was founded in 2017 and is based in San Francisco, California.
ESPs containing Datavant
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The EHR-based patient recruitment market focuses on utilizing electronic health record (EHR) data to identify and recruit eligible patients for clinical trials. This market offers a range of solutions that enable efficient and targeted patient recruitment based on factors such as medical history, demographics, and clinical characteristics. By using EHR-based patient recruitment solutions, research…
Research containing Datavant
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Datavant in 9 CB Insights research briefs, most recently on Aug 10, 2023.
Expert Collections containing Datavant
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Datavant is included in 4 Expert Collections, including Artificial Intelligence.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Precision Medicine Tech Market Map
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Datavant has filed 9 patents.
Latest Datavant News
Sep 20, 2023
Sources point to an influx of deals hitting the market toward the end of summer that may drive volume, especially as pricing has improved. Email address I accept: Email address A link has been emailed to you - check your inbox. Sign in to your account Email address Nearly there! A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: firstname.lastname@example.org . Copyright PEI Media Share with other subscribers Cancel
Datavant Frequently Asked Questions (FAQ)
When was Datavant founded?
Datavant was founded in 2017.
Where is Datavant's headquarters?
Datavant's headquarters is located at 2 Embarcadero Center, San Francisco.
What is Datavant's latest funding round?
Datavant's latest funding round is Series B.
How much did Datavant raise?
Datavant raised a total of $80.5M.
Who are the investors of Datavant?
Investors of Datavant include Roivant Sciences, Johnson & Johnson Innovation, Cigna Ventures, Flex Capital, Transformation Capital and 5 more.
Who are Datavant's competitors?
Competitors of Datavant include Briya and 4 more.
Compare Datavant to Competitors
Medable operates as a global platform for decentralized clinical trials. It solves the systemic challenges inherent in modern clinical trials including access, interoperability between systems, and inefficient technology experiences. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
ConcertAI is a healthcare technology company. It uses artificial intelligence (AI) to help oncologists make more informed treatment decisions for their patients. The platform analyzes large datasets of clinical and genomic data to identify patterns and insights which is used for personalized cancer treatment. It was formerly known as Precision HealthAI. It was founded in 2017 and is based in Cambridge, Massachusetts.
Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility. The company enables physicians to deliver personalized cancer care for patients through analytical and machine-learning platforms. It provides genomic sequencing services and molecular therapeutic data analysis to empower physicians to make real-time, data-driven decisions. It serves clients in the healthcare sector. It was formerly known as Tempus Consulting. The company was founded in 2015 and is based in Chicago, Illinois.
Owkin specializes in developing artificial intelligence (AI) technologies for clinical research and developing drugs and treatments for patients. It empowers researchers in hospitals, universities, and the biopharmaceutical industry to understand drug efficacy varies, improves the drug development process, and help identify key drugs and treatments for individual patients to improve patient outcomes. The company was founded in 2016 and is based in New York, New York.
ePHealth offers a mobile-first end-to-end decentralized clinical trial platform. The platform integrates patients, recruiting sites and coordinating centers. The features of the platform include trial management, trial conduct and patient enrollment. It was founded in 2015 and is based in London, United Kingdom.
nference makes biomedical knowledge computable to solve urgent healthcare problems of biopharmas and medical centers. The company offers EMR data, software products and services, record de-identification, curation of unstructured information, and data creation via digitization of pathology and molecular sequencing. It was founded in 2013 and is based in Cambridge, Massachusetts.